Skip to content

Culturally Specific Interventions: African American Smokers

Culturally Specific Interventions and Acculturation in African American Smokers

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01811758
Acronym
SB2
Enrollment
345
Registered
2013-03-15
Start date
2011-08-31
Completion date
2014-04-30
Last updated
2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking Cessation

Keywords

Culturally Specific Cognitive Behavioral Therapy, Standard Cognitive Behavioral Therapy

Brief summary

The investigators expect that a culturally specific group intervention targeting African American smokers will result in greater smoking cessation rates compared to a standard intervention.

Interventions

BEHAVIORALCulturally Specific CBT
BEHAVIORALStandard CBT

Sponsors

University of Minnesota
CollaboratorOTHER
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. self-identification as African American 2. current smoker of ≥ 5 cigarettes/day or expired CO level of ≥ 8 ppm; 3. age 18-65; 4. able to speak and read English; 5. permanent contact information; 6. access to transportation by public transit or car; 7. no current behavioral or pharmacological treatment ; 8. interest in quitting smoking; (9) have availability to attend sessions.

Exclusion criteria

1. enrolled in another cessation program, 2. do not speak and read English, 3. do not have access to transportation by car or bus to attend sessions, 4. do not have childcare during session times, 5. have contraindications for patch use (pregnant/breastfeeding), 6. if they are in treatment for substance abuse (e.g., illicit drugs, alcohol abuse), 7. if they endorse active addiction to another substance (e.g., illicit drugs or alcohol), 8. if they have been diagnosed with an acute cardiac or respiratory condition; 9. people identified as having a severe mental illness

Design outcomes

Primary

MeasureTime frameDescription
7-day point prevalence abstinenceOverall effect at 12-monthsGeneralized linear mixed model of overall intervention effect.

Secondary

MeasureTime frame
7-day point prevalence abstinence6-months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026